Abstract
1,2,4-Triazolidine-3,5-diones and the 3,5-isoxazolidinedione were, observed to be, potent inhibitors of rat lens aldose reductase activity. In vivo in streptozotocin-diabetic rats, selected agents at 20 mg/kg/day, orally for 21 days reduced significantly the sorbitol levels of rbc, lens and sciatic nerves, suggesting that these derivatives may have some usefulness to treat clinical complications of diabetes mellitus.
Similar content being viewed by others
References
Robison, W. G. R. Jr, Adv. exp. Med. Biol.246 (1988) 365.
Kador, P. F., Med. res. Rev.8 (1988) 325.
Notvest, R. R., and Inserra, J. J., Diabetes36 (1987) 500.
Simard-Dequesne, N., Greseli, E., Dubuc, J., and Dvornik, D., Metabolism34 (1985) 885.
Hansch, C., Sammes, P. G., and Taylor, J. B., Comp. med. Chem.2 (1990) 292.
Humber, L. G., Prog. med. Chem.24 (1987) 299.
Lawson, E. R., Lipinski, C. A., and Sarges, R., Med. res. Rev.8 (1988) 159.
Richon, A. B., Margoudakis, M. E., and Wasvary, J. S. J. med. Chem.25 (1982) 745.
Izydore, R. A., Chapman, J. J., Mitchell, J. A., Cummings, R., Jones, G. T., and Mc Iver, C. D., J. Am. chem. Soc., Perkins TransII (1988) 1415.
Izydore, R. A., and McLean, S., J. chem. Soc.97 (1975) 5611.
Izydore, R. A., and Hall, I. H., U.S. Patent 4, 866,058 (1989).
Izydore, R. A., Hall, I. H., and Simlot, R., Synthesis and Hypolipidemic Activity of 1,2,4-Triazolidine-3,5-diones. ACS Abstract (MEDI 45). Dallas, TX; April 10, 1989.
Izydore, R. A., and Hall, I. H., U.S. Patent 4, 946,963 (1990).
Izydore, R. A., and Hall, I. H., Hypolipidemic Activity of Isoxazolidine-3,5-diones. 3rd Chemical Congress of North America and the 195th ACS National Meeting (MEDI 126). Toronto, Canada, June 1988.
Izydore, R. A., Bernal-Ramirez, J. A., Woodard, T., Okwisa, W. A., Daniels, D. L., Wong, O. T., and Hall, I. H., Eur. J. med. Chem. (1991) submitted.
Hayman, S., and Kinoshita, J. H., J. biol. Chem.240 (1965) 877.
Malone, J. I., Knox, G., Benford, S., and Tedesco, T. A., Diabetes29 (1980) 861.
Simlot, R., Hall, I. H., and Izydore, R. A., Hypolipidemic Activity of Cyclic Hydazide Derivatives. 103rd N.C. Sectional Conference ACS. Chapel Hill, NC, April 15, 1989.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hall, I.H., Izydore, R.A., Simlot, R. et al. Potential aldose reductase inhibitors: 1,2,4-triazolidine-3,5-diones and 2-(3,4,5-trimethoxybenzoyl)-4,4-diethyl-3,5-isoxazolidinedione. Experientia 48, 383–386 (1992). https://doi.org/10.1007/BF01923435
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01923435